Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05774600 · ClinicalTrials.gov registry record · NA

Virtual Sun Safe Workplaces Ph II (SSW Works)

A NA study, sponsored by Klein Buendel.

Completed
Registry status
NA
Development phase
543
Enrollment target

NCT05774600: Completed NA study, sponsored by Klein Buendel.

NCT05774600 is a NA study that has completed, run by Klein Buendel. The registered enrollment target is 543 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05774600, a NA study, has completed, sponsored by Klein Buendel.

COMPLETED
Registry status
NA
Development phase
543 participants
Enrollment target

Study Summary

Americans who work outdoors are exposed to an extreme amount of solar ultraviolet radiation over a lifetime that substantially increases their risk for developing skin cancer. In Phase I, the feasibility of a virtual learning environment (VLE) for distributing the effective Sun Safe Workplaces (SSW) intervention to American employers will be established with input from senior managers and Hispanic and African American outdoor workers and development and evaluation of a prototype of the SSW Works VLE. In Phase II, the full SSW Works will be produced and tested for effectiveness at improving outdoor workers' sun protection in a randomized trial enrolling employers nationwide.

Primary Outcome

Employees will report frequency of sun protection at work (i.e., sunscreen with SPF 30+, long-sleeved shirts, long pants, hat with wide-brim, sunglasses, shade use, limit midday sun exposure, and have sunscreen, hat and eye protection at all times \[1=never, 5=always\]). SPF 30+ is advised in SSW to account for typical under-application that reduces effective SPF.

Interventions

  • BEHAVIORAL SSW Works
  • BEHAVIORAL Minimal Information Control

Trial Details

FieldValue
Enrollment Target 543 participants
Start Date 2023-06-01
Est. Completion 2025-08-28
Phase NA
Klein Buendel

34 total trials

What the finished NCT05774600 record still lists

NCT05774600 is an interventional study that assigns participants to a tested intervention. The registered 543 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% lower).

The record links to 0 conditions, and to 2 interventions - of which SSW Works is the first listed.

NCT05774600 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05774600 about?

NCT05774600 is a clinical study titled "Virtual Sun Safe Workplaces Ph II (SSW Works)". Americans who work outdoors are exposed to an extreme amount of solar ultraviolet radiation over a lifetime that substantially increases their risk for developing skin cancer. In Phase I, the feasibility of a virtual learning environment (VLE) for distributing the effective Sun Safe Workplaces (SSW)...

What is the current status of trial NCT05774600?

This trial is currently completed. It is a NA study. The enrollment target is 543 participants. The study started on 2023-06-01. Estimated completion is 2025-08-28.

What interventions are being tested in trial NCT05774600?

The interventions under investigation include: SSW Works (BEHAVIORAL), Minimal Information Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT05774600?

This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05774600's enrollment target sits among peer trials

543 186th of 2000 higher than 1,814 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07294053 · 543 participants · NA

    Sugary Drink Labeling Study

  • NCT03127761 · 544 participants

    Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

  • NCT04378790 · 544 participants · Phase 3

    A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

  • NCT06118502 · 544 participants · NA

    A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05774600, the US trial registry maintained by the National Library of Medicine. NCT05774600 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.